Major Depressive Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Major Depressive Disorders trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Major Depressive Disorders trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Mood disorders, such as depression and bipolar disorder, are difficult to treat. One reason is that there are no objective ways to measure how these disorders a…
The REACH-tDCS study will evaluate the safety and efficacy of a noninvasive, at-home self-administered Sooma tDCS brain stimulation treatment for Major Depressi…
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military…
Background: Most medications that treat depression take weeks or months to work. Researchers want to develop fast-acting treatments. One dose of ketamine has a…
This is a quasi-experimental, multi-site cluster controlled clinical trial design with two intervention arms--Treatment As Usual (TAU) and an Integrated Care Pa…
This research study seeks to find causes and treatments of depression in teenagers. The study goals are to increase our knowledge of treatments for depression a…
This research study is designed to look at the involvement of the glutamate system in depression. Each subject will undergo a screening appointment to determine…
This study is open to adults between 18 and 65 years of age who have depression (major depressive disorder). People with a current depressive episode lasting be…